156 results
Page 5 of 8
8-K
EX-3.1
zejzp57vh7uk8h
1 Jul 21
Unaudited pro forma condensed combined financial statements
12:00am
8-K
EX-10.18
apd 34kbz51niq
1 Jul 21
Unaudited pro forma condensed combined financial statements
12:00am
8-K
EX-10.2
tk61x3 lmpefj9p1
1 Jul 21
Unaudited pro forma condensed combined financial statements
12:00am
8-K
EX-3.2
aozilgo ni6gzmlna2gq
1 Jul 21
Unaudited pro forma condensed combined financial statements
12:00am
8-K
0pnd 3d5tdfpxwi177h
21 Jun 21
Other Events
4:04pm
425
r5nm1l
21 Jun 21
Business combination disclosure
4:02pm
424B3
h0gkd6xz0kgq9sfxb lk
9 Jun 21
Prospectus supplement
4:42pm
8-K
10lllk93a 96qm7svwjg
9 Jun 21
Other Events
4:40pm
8-K
EX-99.1
nu36cpw cc
9 Jun 21
Other Events
4:40pm
425
1qb90uc
9 Jun 21
Business combination disclosure
4:38pm
425
EX-99.1
tm6sugbveiyhyqv7a2t
9 Jun 21
Business combination disclosure
4:38pm
8-K
EX-99.1
f2me71x7y2t9t7d
4 Jun 21
POINT Biopharma Announces First Patients
4:22pm
8-K
lfwqct hgmku7yo
4 Jun 21
POINT Biopharma Announces First Patients
4:22pm
425
EX-99.1
6zozi94m ymik8d5o24
4 Jun 21
Business combination disclosure
4:20pm
425
gnld x2hgoc7j
4 Jun 21
Business combination disclosure
4:20pm
8-K
t3ze9 moc2h
1 Jun 21
POINT Biopharma Receives U.S. Nuclear Regulatory Commission Materials License for Indiana Facility
4:32pm
8-K
EX-99.1
m18ah1cot6yhgcr66wz
1 Jun 21
POINT Biopharma Receives U.S. Nuclear Regulatory Commission Materials License for Indiana Facility
4:32pm
425
93ki5
1 Jun 21
Business combination disclosure
4:30pm
425
EX-99.1
a780nm 32mzxqg
1 Jun 21
Business combination disclosure
4:30pm